CommonWealth Mag: Gene editing for plants could feed the world
THE NEW ENGLAND life sciences industry has produced an explosion of therapies for small patient populations with rare diseases. Last year, fully half of newly approved drugs were for these smaller populations.
While emerging biotech therapies provide hope for small clusters of human patients with rare diseases, when deployed to the agricultural sector, biotech advances the promise nourishment for tens of millions who may otherwise face food shortages that are increasingly exacerbated by drought and pestilence. When it comes to agriculture, biotech not only provides hope that the many might avoid food scarcity but also represents a promising opportunity for the New England economy.